

Intended Use
CRP/SAA Combo Rapid Test Kit(LFIA) is used for the in vitro qualitative detection of C-Reactive Protein/Serum Amyloid A (CRP/SAA) content in human whole blood, plasma and serum.Product Performance
1. Precision
The CRP and SAA positive controls were tested, and the results were all positive.
3.Analysis of specificity
The result of detection of CRP and SAA specific quality control products (negative serum or plasma samples) should be negative.
4. The limit of detection
CRP is no higher than 10mg/L, SAA is no higher than 10mg/L.
5. Interfering substances
The samples with hemolysis, hyperlipemia, and jaundice do not interfere with the test results and can be used as testing sample.
6. Clinical results
The rapid detection method and CLIA method were used to detect 1,120 cases of susceptible persons. The comparison of each subject is shown in the following table:
CRP/SAA Combo Rapid Test Kit | CLIA | Total | |
SAA Positive | Negative | ||
SAA Positive | 263 | 5 | 268 |
Negative | 3 | 551 | 554 |
Total | 266 | 556 | 822 |
Sensitivity: 98.1%, specificity: 99.45%, overall consistency: 99.02%




